EN
登录

渤健豪掷20亿美元扩建美国药物制造设施

Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing

benzinga 等信源发布 2025-07-21 14:25

可切换为仅中文


Biogen Inc.

百健公司

BIIB

百健公司

said on Monday that it plans to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research

周一表示,计划在其位于北卡罗来纳州研究区的现有制造基地额外投资20亿美元。

Triangle Park (RTP)

三角研究园 (RTP)

.

Biogen has invested approximately $10 billion in its North Carolina manufacturing footprint to date, including more than $3 billion in recent years, and this upcoming investment will fuel the continued advancement of Biogen’s

迄今为止,Biogen已在其北卡罗来纳州的制造基地投资了约100亿美元,其中近年来投资超过30亿美元,而这项即将到来的投资将推动Biogen的持续发展。

late-stage clinical pipeline

晚期临床管线

.

In the next few years, Biogen plans to continue investing in multiple modalities and factories across the company’s two campuses in RTP.

未来几年,Biogen计划继续投资RTP两个园区的多种模式和工厂。

These investments will include further expanding the antisense oligonucleotide (ASO) capabilities and infrastructure, establishing clinical and commercial multi-platform fill finish capabilities, and modernizing manufacturing technologies and controls through further advanced automation and artificial intelligence..

这些投资将包括进一步扩展反义寡核苷酸(ASO)的能力和基础设施,建立临床和商业多平台填充完成能力,以及通过进一步的先进自动化和人工智能实现制造技术和控制的现代化。

Also Read:

另请阅读:

Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis’ Zolgensma

Biogen-Ionis合作药物在曾接受诺华Zolgensma治疗的脊髓性肌萎缩症儿童中显示出益处

“Our manufacturing footprint in the United States has played a critical role in Biogen’s history and success and in advancing the treatments … With this investment, we will modernize and expand our manufacturing capability to enable our pipeline and provide resilient patient supply…,” said Nicole Murphy, head of pharmaceutical operations and technology at Biogen..

“我们在美国的制造基地在渤健的历史和成功以及推进治疗方面发挥了关键作用……通过这项投资,我们将实现生产能力和技术的现代化并扩大规模,以支持我们的产品线并提供有弹性的患者供应……”渤健制药运营和技术主管妮可·墨菲表示。

North Carolina’s RTP is home to Biogen’s largest manufacturing footprint.

北卡罗来纳州的RTP是Biogen最大制造基地的所在地。

As the state’s largest biotechnology employer and one of the top five biopharmaceutical employers, Biogen employs over 1,500 manufacturing and technical employees and more than 400 skilled contractors across its Wake County and Durham County campuses.

作为该州最大的生物技术雇主和前五大生物制药雇主之一,Biogen 在其韦克县和达勒姆县的园区雇佣了超过 1,500 名制造和技术员工以及 400 多名熟练承包商。

More than 90% of commercial medicines produced by Biogen have manufacturing and quality control testing in the U.S.

超过90%的百健生产的商业药品在美国进行生产和质量控制测试。

Earlier in May, U.S. President

五月初,美国总统

Donald Trump’s

唐纳德·特朗普的

signed an executive order to promote prescription drug manufacturing in the U.S., streamlining the path for companies to build new production sites as potential tariffs on

签署了一项行政命令,以促进美国的处方药生产,为各公司建立新的生产场地简化路径,作为对潜在关税的应对措施。

imported medicines loom

进口药品迫在眉睫

.

The White House wants facilities to come on board at a faster rate. It

白宫希望设施能以更快的速度加入。

estimates

估计

that it can currently take five to 10 years to build new pharmaceutical manufacturing capacity, which it calls “unacceptable from a national-security standpoint.'

目前,新建制药生产能力需要5到10年的时间,它称“从国家安全的角度来看,这是不可接受的”。

Amid tariff uncertainty

关税不确定性之中

, many drug companies are investing to boost production within the U.S.:

,许多制药公司正在投资以提高美国本土的产量:

Trending Investment Opportunities

投资机会趋势

Advertisement

广告

Arrived

到达

Buy shares of homes and vacation rentals for as little as $100.

只需 100 美元,即可购买房屋和度假租赁的股份。

Get Started

开始使用

WiserAdvisor

智慧顾问

Get matched with a trusted, local financial advisor for free.

免费匹配值得信赖的当地财务顾问。

Get Started

开始使用

Point.com

点点网

Tap into your home's equity to consolidate debt or fund a renovation.

利用您房屋的净值来整合债务或为装修提供资金。

Get Started

开始使用

Robinhood

罗宾汉

Move your 401k to Robinhood and get a 3% match on deposits.

将您的401k转移到Robinhood,并获得存款3%的匹配。

Get Started

开始使用

Eli Lilly And Co

礼来公司

doubled

翻倍

domestic medicine production

国内药品生产

.

Thermo Fisher Scientific Inc.

赛默飞世尔科技公司

announced it would invest an additional $2 billion in the U.S. over

宣布将额外投资20亿美元在美国,超过

the next four years

接下来的四年

.

Medtech firm

医疗技术公司

Becton, Dickinson, and Company

碧迪公司

also announced its intention to invest $2.5 billion in U.S. manufacturing capacity

还宣布了其投资25亿美元用于美国制造业产能的计划

over the next five years

未来五年内

.

Regeneron Pharmaceuticals, Inc.

再生元制药公司

seeks to nearly double its manufacturing capacity through a new agreement with

通过与...的新协议,寻求将其制造能力提高近一倍

FUJIFILM Diosynth Biotechnologies

富士胶片戴奥斯ynth生物技术公司

.

Novartis AG

诺华公司

unveiled a $23 billion investment plan to expand in the U.S.

公布了一项230亿美元的投资计划,以扩大其在美国的业务。

over the next five years

未来五年内

.

Johnson & Johnson

强生公司

plans to invest more than

计划投资超过

$55 billion in the U.S. over the next four years

未来四年美国将投入550亿美元

.

Roche Holdings AG

罗氏控股公司

announced that it will invest $50 billion in the U.S. over

宣布将投资500亿美元在美国。

the next five years.

未来五年。

Bristol-Myers Squibb & Co.’s

百时美施贵宝公司

Christopher Boerner, chair and chief executive officer,

克里斯托弗·博尔纳,董事长兼首席执行官,

shared

共享

plans to invest $40 billion in U.S. R&D, technology, and manufacturing over the next five years.

计划在未来五年内投资 400 亿美元用于美国的研发、技术和制造业。

Sanofi SA

赛诺菲公司

announced it will invest at least $20 billion in the

宣布将至少投资 200 亿美元于

U.S. through 2030

美国到2030年

. The bulk of the spending will go to R&D and U.S. manufacturing.

大部分支出将用于研发和美国制造业。

BIIB Price Action:

BIIB价格走势:

BIIB stock is down 1.46% at $123.17 at publication on Monday.

BIIB股票在周一发布时下跌1.46%,至123.17美元。

Loading...

加载中...

Loading...

加载中...

Read Next:

接下来读:

Elon Musk’s Tesla Announces 3 Million Model 3 Units Sold Worldwide

埃隆·马斯克的特斯拉宣布全球售出300万辆Model 3车型

Photo Courtesy: PeopleImages.com, Yuri A on Shutterstock

照片来源:PeopleImages.com,Shutterstock上的Yuri A

BIIB

百健

Biogen Inc

渤健公司

$123.21

123.21美元

-1.43

-1.43

%

%

Stock Score Locked: Want to See it?

库存评分已锁定:想看看吗?

Benzinga Rankings give you vital metrics on any stock – anytime.

Benzinga排名为您提供任何股票的关键指标——随时随地。

Reveal Full Score

显示完整分数

Edge Rankings

边缘排名

Momentum

动量

14.40

14.40

Growth

增长

40.47

40.47

Quality

质量

21.31

21.31

Value

41.26

41.26

Price Trend

价格趋势

Short

短的

Medium

中等

Long

Overview

概述

Market News and Data brought to you by Benzinga APIs

Benzinga API为您提供市场新闻和数据

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

© 2025 Benzinga.com. Benzinga 不提供投资建议。保留所有权利。